# Bioreliance Corporation – FDA Inspection, Aug 4, 2023

Source: https://www.keypedia.com/records/fda_inspections/bioreliance-corporation/89149f6b-0201-4f3c-9500-60de669dfba4
Source feed: FDA_Inspections

> FDA inspection 1215040 of Bioreliance Corporation, August 04, 2023. Classification: No Action Indicated (NAI). 11 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1215040
- Company Name: Bioreliance Corporation
- Inspection Date: 2023-08-04
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1295306 - 2026-01-29](https://www.keypedia.com/records/fda_inspections/bioreliance-corporation/e199758b-3727-437f-82a7-ea444bde9780)
- [FDA Inspection 1254934 - 2024-11-22](https://www.keypedia.com/records/fda_inspections/bioreliance-corporation/7941bc6b-db19-4266-b05d-af8a19fbde51)
- [FDA Inspection 1099981 - 2019-08-08](https://www.keypedia.com/records/fda_inspections/bioreliance-corporation/7e151514-be3f-4b8f-ba64-e4ad411f7cc0)
- [FDA Inspection 1059115 - 2018-07-13](https://www.keypedia.com/records/fda_inspections/bioreliance-corporation/ba69306a-6c03-404f-b4e3-7b18e0e140f0)
- FDA Inspection 983525 - 2016-01-11

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/norman-k-starks/4b8776e0-f96e-429c-94d1-40c0369f5378)

Company: https://www.keypedia.com/companies/bioreliance-corporation/08d3dc20-6c7e-4f04-bb98-bbc868e70000

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
